Skip to Main Content

Author Details

Joachim Havla
Institute of Clinical Neuroimmunology, LMU Hospital, Ludwig Maximilians University
2009
96
25
PMIDPaper TitleJournal TitlePublished Year
37920967Association between retinal thickness and disease characteristics in adult epilepsy: A cross-sectional OCT evaluation.Epilepsia Open2024
38086777Time to Disability Milestones and Annualized Relapse Rates in NMOSD and MOGAD.Ann Neurol2024
38000130Patient-reported outcome parameters and disability worsening in progressive multiple sclerosis.Mult Scler Relat Disord2024
37676297Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management.J Neurol2024
35913055Structured Reporting in Multiple Sclerosis - Consensus-Based Reporting Templates for Magnetic Resonance Imaging of the Brain and Spinal Cord.Rofo2023
37562402Distinct molecular profiles of skull bone marrow in health and neurological disorders.Cell2023
37712413Therapy challenges for NMOSD in a patient with HIV.Mult Scler2023
37629053Inner Retinal Layer Changes Reflect Changes in Ambulation Score in Patients with Primary Progressive Multiple Sclerosis.Int J Mol Sci2023
37158303Age-dependent retinal neuroaxonal degeneration in children and adolescents with Leber hereditary optic neuropathy under idebenone therapy.Eur J Neurol2023
37089005MOG-IgG-Associated Bilateral Optic Neuritis in Temporal Relation to Monkeypox Vaccination.Ann Neurol2023
37022481Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis.J Neurol2023
37435157Case report: Anti septin-5-encephalitis as a treatable cause of cerebellar ataxia and psychiatric symptoms.Front Neurol2023
36993939Retrospective cohort study to devise a treatment decision score predicting adverse 24-month radiological activity in early multiple sclerosis.Ther Adv Neurol Disord2023
36786424Cognition in patients with neuromyelitis optica spectrum disorders: A prospective multicentre study of 217 patients (CogniNMO-Study).Mult Scler2023
36810323Diagnostic value of intereye difference metrics for optic neuritis in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders.J Neurol Neurosurg Psychiatry2023
36908609The Acute Optic Neuritis Network (ACON): Study protocol of a non-interventional prospective multicenter study on diagnosis and treatment of acute optic neuritis.Front Neurol2023
36902816Optical Coherence Tomography: Retinal Imaging Contributes to the Understanding of Brain Pathology in Classical Galactosemia.J Clin Med2023
36245037Peripapillary hyper-reflective ovoid mass-like structures (PHOMS) in AQP4-IgG-positive neuromyelitis optica spectrum disease (NMOSD) and MOG-IgG-associated disease (MOGAD).J Neurol2023
34115170First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine.J Neurol2022
35703428Longitudinal Retinal Changes in MOGAD.Ann Neurol2022
35764402The Role of Optical Coherence Tomography Criteria and Machine Learning in Multiple Sclerosis and Optic Neuritis Diagnosis.Neurology2022
36247773Serum glial fibrillary acidic protein and neurofilament light chain in patients with early treated phenylketonuria.Front Neurol2022
35869995Characteristic retinal atrophy pattern allows differentiation between pediatric MOGAD and MS after a single optic neuritis episode.J Neurol2022
36126540Clinical onset of CNS demyelinating disease after COVID-19 vaccination: denovo disease?Mult Scler Relat Disord2022
36049213Normative Data and Conversion Equation for Spectral-Domain Optical Coherence Tomography in an International Healthy Control Cohort.J Neuroophthalmol2022
35289375Antibody Therapies for Progressive Multiple Sclerosis and for Promoting Repair.Neurotherapeutics2022
35082170Costs and Health-Related Quality of Life in Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Disease: CHANCE<sup>NMO</sup> Study.Neurology2022
34609601SARS-CoV-2 antibody seroprevalence in a large neuroimmunological patient cohort.J Neurol2022
34711650Astrocytic outer retinal layer thinning is not a feature in AQP4-IgG seropositive neuromyelitis optica spectrum disorders.J Neurol Neurosurg Psychiatry2022
33423336Pain, depression, and quality of life in adults with MOG-antibody-associated disease.Eur J Neurol2021
33910937APOSTEL 2.0 Recommendations for Reporting Quantitative Optical Coherence Tomography Studies.Neurology2021
33757118TSPO PET imaging of natalizumab-associated progressive multifocal leukoencephalopathy.Brain2021
34956063Optical Coherence Tomography to Assess Neurodegeneration in Phenylalanine Hydroxylase Deficiency.Front Neurol2021
34374178Association of peripapillary hyper-reflective ovoid masslike structures and disease duration in primary progressive multiple sclerosis.Eur J Neurol2021
34755108Relapse-independent multiple sclerosis progression under natalizumab.Brain Commun2021
34210800Effects of Natalizumab Therapy on Intrathecal Immunoglobulin G Production Indicate Targeting of Plasmablasts.Neurol Neuroimmunol Neuroinflamm2021
34171607Multiple sclerosis and subclinical neuropathology in healthy individuals with familial risk: A scoping review of MRI studies.Neuroimage Clin2021
34261026Oral pulsed therapy of relapsing multiple sclerosis with cladribine tablets - expert opinion on issues in clinical practice.Mult Scler Relat Disord2021
34051804Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well?J Neuroinflammation2021
34108267Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder: A Cross-Sectional Study of 166 AQP4 Antibody-Seropositive Patients.Neurol Neuroimmunol Neuroinflamm2021
31535177[Seronegative myasthenic syndrome?]Nervenarzt2020
31796527Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders.Neurology2020
33219036Anti-MOG antibody-associated disorders: differences in clinical profiles and prognosis in Japan and Germany.J Neurol Neurosurg Psychiatry2020
33122310Cohort profile: a collaborative multicentre study of retinal optical coherence tomography in 539 patients with neuromyelitis optica spectrum disorders (CROCTINO).BMJ Open2020
32576604Altered fovea in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders.Neurol Neuroimmunol Neuroinflamm2020
32796248TSPO PET With 18F-GE-180 to Differentiate Variants of Multiple Sclerosis: Relapsing-Remitting Multiple Sclerosis, Tumefactive Demyelination, and Baló's Concentric Sclerosis.Clin Nucl Med2020
32989121Author response: Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders.Neurology2020
32589804Inner retinal layer thinning in radiologically isolated syndrome predicts conversion to multiple sclerosis.Eur J Neurol2020
32478196Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot study.Contemp Clin Trials Commun2020
32388243Possible link of genetic variants to autoimmunity in GAD-antibody-associated neurological disorders.J Neurol Sci2020
  • 1 - 50 of 96

Recommended Authors

University of Arizona College of Medicine
Career Start Year 2013
Number of shared co-authors 0
Children's Hospital Los Angeles
Career Start Year 2013
Number of shared co-authors 0
Johns Hopkins University School of Medicine
Career Start Year 2012
Number of shared co-authors 7
Columbia University Medical Center
Career Start Year 2012
Number of shared co-authors 0
University of Colorado School of Medicine
Career Start Year 2012
Number of shared co-authors 0
Royal College of Surgeons in Ireland
Career Start Year 2010
Number of shared co-authors 0
University of Virginia Medical Center
Career Start Year 2008
Number of shared co-authors 0
Boston Children's Hospital, Harvard Medical School
Career Start Year 2007
Number of shared co-authors 1
St. Vincent's University Hospital
Career Start Year 2007
Number of shared co-authors 1
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 2006
Number of shared co-authors 9
Yale University
Career Start Year 2005
Number of shared co-authors 1
University of Pittsburgh
Career Start Year 2003
Number of shared co-authors 1
The University of Texas Southwestern Medical Center
Career Start Year 2003
Number of shared co-authors 10
University of California san francisco
Career Start Year 1997
Number of shared co-authors 5
University of California san francisco
Career Start Year 1995
Number of shared co-authors 8
University of Massachusetts Medical School
Career Start Year 1993
Number of shared co-authors 9
University of Pennsylvania/Ophthalmology
Career Start Year 1993
Number of shared co-authors 7
Tokyo Women's Medical University School of Medicine
Career Start Year 1992
Number of shared co-authors 0
McMaster University
Career Start Year 1991
Number of shared co-authors 0
The Ohio State University Wexner Medical Center
Career Start Year 1991
Number of shared co-authors 6
Department of Pharmaceutical Sciences, State University of New York
Career Start Year 1991
Number of shared co-authors 0
Fondazione IRCCS Istituto Neurologico Carlo Besta
Career Start Year 1988
Number of shared co-authors 0
Swedish Neuroscience Institute
Career Start Year 1987
Number of shared co-authors 3
Biomedicine and Clinical Research, University Hospital Basel, University of Basel
Career Start Year 1985
Number of shared co-authors 7
Massachusetts General Hospital and Harvard Medical School
Career Start Year 1984
Number of shared co-authors 1
Southend Hospital NHS Trust
Career Start Year 1983
Number of shared co-authors 0
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 2
Weill Institute for Neurosciences, University of California san francisco
Career Start Year 1980
Number of shared co-authors 9
University of Alabama at Birmingham
Career Start Year 1976
Number of shared co-authors 11
Massachusetts General Hospital
Career Start Year 1960
Number of shared co-authors 1

Collaborators

Max-Delbruck Center for Molecular Medicine in the Helmholtz Association
Co-authored papers 27
Max-Delbruck Center for Molecular Medicine in the Helmholtz Association
Co-authored papers 17
Max-Delbruck Center for Molecular Medicine in the Helmholtz Association
Co-authored papers 16
Technical University of Munich
Co-authored papers 14
Co-authored papers 14
Technical University of Munich
Co-authored papers 11
Co-authored papers 10
Fundacio Recerca Clinic Barcelona -IDIBAPS
Co-authored papers 10
Vita-Salute University & Hospital San Raffaele
Co-authored papers 8
TUM School of Medicine, Technical University of Munich
Co-authored papers 7
Moorfields Eye Hospital
Co-authored papers 7
Oxford University
Co-authored papers 7
Hospital Clinic of Barcelona-Institut d'Investigacions
Co-authored papers 7
Johns Hopkins University School of Medicine
Co-authored papers 6
Johns Hopkins University School of Medicine
Co-authored papers 6
Vrije Universiteit Amsterdam
Co-authored papers 6
Department of Neurology and NYU Grossman School of Medicine
Co-authored papers 5
Dr. von Hauner Children's Hospital, Ludwig-Maximilians-University
Co-authored papers 4
Ibn Sina Hospital
Co-authored papers 4
and of Biochemistry and Pharmacy, University of Tuebingen
Co-authored papers 4
Stanford University School of Medicine
Co-authored papers 4
Stanford University School of Medicine
Co-authored papers 4
NYU Grossman School of Medicine
Co-authored papers 3
Department of Neurology and NYU Grossman School of Medicine
Co-authored papers 3
Dasman Institute
Co-authored papers 3
Bascom Palmer Eye Institute, University of Miami Miller School of Medicine
Co-authored papers 3
NYU Grossman School of Medicine
Co-authored papers 3
The Hospital for Sick Children
Co-authored papers 3
University Hospital Basel
Co-authored papers 3
Technical University
Co-authored papers 2